Trials / Sponsors / Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML Acute Myelogenous Leukemia, Acute Myeloid Leukemia | Phase 1 | 2014-02-01 |